Table 2.
Cell system | Concentration of enisamium (mean ± SD, ng/106 cells)a |
Permeability(mean ± SD, %)b | |
---|---|---|---|
Initial input | Intracellular | ||
MDCK cells | 35,300 ± 1700 | 27.9 ± 1.4 | 0.08 ± 0.01 |
Undifferentiated NHBE cells | 487,000 ± 2200 | 4110 ± 830 | 0.85 ± 0.21 |
Differentiated NHBE cells | 568,000 ± 42,000 | 10,700 ± 1900 | 1.90 ± 0.20 |
MDCK: Madin–Darby canine kidney; NHBE: normal human bronchial epithelial.
aThe cells were overlaid with medium containing enisamium (100 µM of enisamium iodide for MDCK cells and 2000 µM of enisamium chloride for undifferentiated and dNHBE cells) and incubated at 37°C under 5% CO2 for 24 h (n = 3 wells). The cellular lysates and supernatants were harvested and the concentration of enisamium was determined using LC–MS/MS. Concentration is expressed as nanograms (ng) per 106 cells.
bPermeability of enisamium was calculated as the ratio of the intracellular concentration to that in the initial drug input, and expressed as percentage.